PFMT with biofeedback + Home PFMT
Other24 outpatient sessions PFMT with biofeedback (twice a week). Simultaneously, it was prescribed a home exercise daily program during three months (supervised treatment).
Other names: Biofeedback
NCT Number: NCT02851719
To test whether biofeedback (BF) added to pelvic floor muscle training (PFMT) promotes additional benefits over PFMT alone in the stress urinary incontinence (SUI) treatment.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Introduction: The aim of this study was to test the hypothesis that outpatient BF added to home PFMT results in increased frequency of home exercises sets per month performed by the patients and objective cure rate after 3 months of supervised training. Secondarily, to investigate other subjective and objective clinical parameters in the groups that received or not BF together with PFMT after 3 months of supervised training, and in a longer term of 9-month follow-up.
Method: 72 incontinent women were randomized to the: BF Group (outpatient BF + home PFMT) or PFMT Group (outpatient PFMT + home PFMT).
Assessments: baseline after 3 months of supervised treatment and at 9-month follow-up (after 6 additional months of home PFMT without supervision).
Primary outcomes: adherence - monthly exercises sets performed (exercise diary) and objective cure of SUI (pad test) after 3 months.
Secondary outcomes: urinary symptoms, muscle function, quality of life, adhesion and subject cure at the two time-points.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
24 outpatient sessions PFMT with biofeedback (twice a week). Simultaneously, it was prescribed a home exercise daily program during three months (supervised treatment).
Other names: Biofeedback
24 outpatient sessions PFMT without biofeedback (twice a week). Simultaneously, it was prescribed a home exercise daily program during three months (supervised treatment).
Other names: PFMT alone
Time frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To quantify the severity of SUI and as the tool to estimate objective cure rate
Time frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To assess the loss efforts
Time frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To assess the function of the pelvic floor muscle
Time frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To assess the function of the pelvic floor muscle
Time frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To quantify the impact of SUI on quality of life
Time frame: After 3 months of supervised treatment and at 9-month follow-up
To evaluate the patient satisfaction with treatment
Time frame: After 3 months of supervised treatment and at 9-month follow-up
The weekly frequency (days/week that patients performed at least 1 set of exercises) and the number of sets per day
Time frame: After 3 months of supervised treatment
The frequency of the outpatient sessions was monitored
Federal University of São Paulo
Other
Outpatient Biofeedback in Addition to Home Pelvic Floor Muscle Training for Stress Urinary Incontinence: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03325543
Behavior, Female Urogenital Diseases
São Paulo, Brazil
View Trial DetailsNCT03058042
Behavior, Female Urogenital Diseases
São Paulo, Brazil
View Trial DetailsNCT04114266
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsNCT04171531
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial Details